Neoadjuvant intratumoral influenza vaccine treatment in patients with proficient mismatch repair colorectal cancer leads to increased tumor infiltration of CD8+ T cells and upregulation of PD-L1: a phase 1/2 clinical trial.
Gögenur M, Balsevicius L, Bulut M, Colak N, Justesen TF, Fiehn AK, Jensen MB, Høst-Rasmussen K, Cappelen B, Gaggar S, Tajik A, Zahid JA, Bennedsen ALB, D'Ondes TDB, Raskov H, Sækmose SG, Hansen LB, Salanti A, Brix S, Gögenur I.
Gögenur M, et al. Among authors: bennedsen alb.
J Immunother Cancer. 2023 May;11(5):e006774. doi: 10.1136/jitc-2023-006774.
J Immunother Cancer. 2023.
PMID: 37172969
Free PMC article.
Clinical Trial.